Feedback / Questions
Dupixent (dupilumab) - Sanofi, Regeneron
eblasakimab (ASLAN004) - ASLAN Pharma, Zenyaku Holdings
http://clinicaltrials.gov/ct2/show/NCT05694884
Jan 18, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next